Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion

The use of blood for normothermic and subnormothermic kidney preservation hinders the translation of these approaches and promising therapeutics. This study evaluates whether adding hydrogen sulfide donor AP39 to Hemopure, a blood substitute, during subnormothermic perfusion improves kidney outcomes...

Full description

Bibliographic Details
Main Authors: Smriti Juriasingani, Ashley Jackson, Max Yulin Zhang, Aushanth Ruthirakanthan, George J. Dugbartey, Emrullah Sogutdelen, Max Levine, Moaath Mandurah, Matthew Whiteman, Patrick Luke, Alp Sener
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/13/7180
_version_ 1797528018565988352
author Smriti Juriasingani
Ashley Jackson
Max Yulin Zhang
Aushanth Ruthirakanthan
George J. Dugbartey
Emrullah Sogutdelen
Max Levine
Moaath Mandurah
Matthew Whiteman
Patrick Luke
Alp Sener
author_facet Smriti Juriasingani
Ashley Jackson
Max Yulin Zhang
Aushanth Ruthirakanthan
George J. Dugbartey
Emrullah Sogutdelen
Max Levine
Moaath Mandurah
Matthew Whiteman
Patrick Luke
Alp Sener
author_sort Smriti Juriasingani
collection DOAJ
description The use of blood for normothermic and subnormothermic kidney preservation hinders the translation of these approaches and promising therapeutics. This study evaluates whether adding hydrogen sulfide donor AP39 to Hemopure, a blood substitute, during subnormothermic perfusion improves kidney outcomes. After 30 min of renal pedicle clamping, porcine kidneys were treated to 4 h of static cold storage (SCS-4 °C) or subnormothermic perfusion at 21 °C with Hemopure (H-21 °C), Hemopure + 200 nM AP39 (H200nM-21 °C) or Hemopure + 1 µM AP39 (H1µM-21 °C). Then, kidneys were reperfused with Hemopure at 37 °C for 4 h with metabolic support. Perfusate composition, tissue oxygenation, urinalysis and histopathology were analyzed. During preservation, the H200nM-21 °C group exhibited significantly higher urine output than the other groups and significantly higher tissue oxygenation than the H1µM-21 °C group at 1 h and 2h. During reperfusion, the H200nM-21 °C group exhibited significantly higher urine output and lower urine protein than the other groups. Additionally, the H200nM-21 °C group exhibited higher perfusate pO<sub>2</sub> levels than the other groups and significantly lower apoptotic injury than the H-21 °C and the H1µM-21 °C groups. Thus, subnormothermic perfusion at 21 °C with Hemopure + 200 nM AP39 improves renal outcomes. Additionally, our novel blood-free model of ex vivo kidney preservation and reperfusion could be useful for studying other therapeutics.
first_indexed 2024-03-10T09:52:09Z
format Article
id doaj.art-c9ed6530a9ff4d48a61f71e9c4b83d66
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T09:52:09Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c9ed6530a9ff4d48a61f71e9c4b83d662023-11-22T02:41:37ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-07-012213718010.3390/ijms22137180Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and ReperfusionSmriti Juriasingani0Ashley Jackson1Max Yulin Zhang2Aushanth Ruthirakanthan3George J. Dugbartey4Emrullah Sogutdelen5Max Levine6Moaath Mandurah7Matthew Whiteman8Patrick Luke9Alp Sener10Department of Microbiology and Immunology, Western University, London, ON N6A 5C1, CanadaMatthew Mailing Center for Translational Transplant Studies, London Health Sciences Centre, London, ON N6A 5A5, CanadaDepartment of Microbiology and Immunology, Western University, London, ON N6A 5C1, CanadaMatthew Mailing Center for Translational Transplant Studies, London Health Sciences Centre, London, ON N6A 5A5, CanadaMatthew Mailing Center for Translational Transplant Studies, London Health Sciences Centre, London, ON N6A 5A5, CanadaDepartment of Urology, Bolu Abant Izzet Baysal University, Bolu 14030, TurkeyMatthew Mailing Center for Translational Transplant Studies, London Health Sciences Centre, London, ON N6A 5A5, CanadaMatthew Mailing Center for Translational Transplant Studies, London Health Sciences Centre, London, ON N6A 5A5, CanadaSt. Luke’s Campus, University of Exeter Medical School, Exeter EX1 2HZ, UKMatthew Mailing Center for Translational Transplant Studies, London Health Sciences Centre, London, ON N6A 5A5, CanadaDepartment of Microbiology and Immunology, Western University, London, ON N6A 5C1, CanadaThe use of blood for normothermic and subnormothermic kidney preservation hinders the translation of these approaches and promising therapeutics. This study evaluates whether adding hydrogen sulfide donor AP39 to Hemopure, a blood substitute, during subnormothermic perfusion improves kidney outcomes. After 30 min of renal pedicle clamping, porcine kidneys were treated to 4 h of static cold storage (SCS-4 °C) or subnormothermic perfusion at 21 °C with Hemopure (H-21 °C), Hemopure + 200 nM AP39 (H200nM-21 °C) or Hemopure + 1 µM AP39 (H1µM-21 °C). Then, kidneys were reperfused with Hemopure at 37 °C for 4 h with metabolic support. Perfusate composition, tissue oxygenation, urinalysis and histopathology were analyzed. During preservation, the H200nM-21 °C group exhibited significantly higher urine output than the other groups and significantly higher tissue oxygenation than the H1µM-21 °C group at 1 h and 2h. During reperfusion, the H200nM-21 °C group exhibited significantly higher urine output and lower urine protein than the other groups. Additionally, the H200nM-21 °C group exhibited higher perfusate pO<sub>2</sub> levels than the other groups and significantly lower apoptotic injury than the H-21 °C and the H1µM-21 °C groups. Thus, subnormothermic perfusion at 21 °C with Hemopure + 200 nM AP39 improves renal outcomes. Additionally, our novel blood-free model of ex vivo kidney preservation and reperfusion could be useful for studying other therapeutics.https://www.mdpi.com/1422-0067/22/13/7180kidney preservationkidney transplantationhydrogen sulfide (H<sub>2</sub>S)AP39donation after cardiac death (DCD)subnormothermic
spellingShingle Smriti Juriasingani
Ashley Jackson
Max Yulin Zhang
Aushanth Ruthirakanthan
George J. Dugbartey
Emrullah Sogutdelen
Max Levine
Moaath Mandurah
Matthew Whiteman
Patrick Luke
Alp Sener
Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion
International Journal of Molecular Sciences
kidney preservation
kidney transplantation
hydrogen sulfide (H<sub>2</sub>S)
AP39
donation after cardiac death (DCD)
subnormothermic
title Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion
title_full Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion
title_fullStr Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion
title_full_unstemmed Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion
title_short Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion
title_sort evaluating the effects of subnormothermic perfusion with ap39 in a novel blood free model of ex vivo kidney preservation and reperfusion
topic kidney preservation
kidney transplantation
hydrogen sulfide (H<sub>2</sub>S)
AP39
donation after cardiac death (DCD)
subnormothermic
url https://www.mdpi.com/1422-0067/22/13/7180
work_keys_str_mv AT smritijuriasingani evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT ashleyjackson evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT maxyulinzhang evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT aushanthruthirakanthan evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT georgejdugbartey evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT emrullahsogutdelen evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT maxlevine evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT moaathmandurah evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT matthewwhiteman evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT patrickluke evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion
AT alpsener evaluatingtheeffectsofsubnormothermicperfusionwithap39inanovelbloodfreemodelofexvivokidneypreservationandreperfusion